Editor's take: Google has long moved away from its "don't be evil" motto, instead deepening its involvement with US defense-related initiatives. The company is reportedly providing expanded access to ...

Editor's take: Large language models and other AI technologies have increased the number of tools scammers can use to impersonate people over the phone. Google is now trying to fight this "phone slop" ...

It’s tough to eat healthy under any circumstances, let alone when you’re stressed. But now, new research suggests a hack to help you eat healthy, even when you’re completely frazzled. It’s called ...

This tutorial shows how to speed up your video editing workflow using AI-assisted tools alongside Adobe Premiere Pro. It covers practical ways to structure edits, automate repetitive tasks, and ...

We've come to think of Buc-ee's as so big they resemble city-states, with tens of thousands of square footage and fields of gas pumps and toilets. But there was a time in the 1980s when Buc-ee's was ...

You don’t notice it at first. The climb goes well. The views are worth it. You hang out at the summit a little longer than planned. Then you start down, and something shifts. Your socks are damp and ...

April 13 (Reuters) - The use of Tylenol by women during pregnancy was not associated with autism in their children, according to results of a nationwide study in Denmark published on Monday. Among ...

Scientists believe they may have found the least we can do to change our habits and still meaningfully improve our health and longevity. In a new study involving tens of thousands of men and women, ...

The last decade has seen vast improvements in humanoid robots, but graduating to widespread use might require going back to the fundamentals. “Not reliably,” Hurst said. “I don’t think it’s totally ...

After introducing the security measure in 2024, the Find Hub app (previously Find My Device) no longer requires biometric confirmation. Find Hub no longer asks for your fingerprint or PIN before ...

Eligible patients had locally advanced or metastatic NSCLC with prespecific actionable GAs, had progressed after standard treatment and received no more than one previous line of chemotherapy.